Abstract
Glucagon-like peptide-1 (GLP-1) analogues have emerged as promising therapeutic agents for the treatment of type 2 diabetes. Recent studies have suggested a potential role of GLP-1 in reproductive functions, offering new avenues for fertility treatment. This paper aims to review the current understanding of GLP-1 analogues to human reproduction, focusing on their potential application in fertility treatment, and discussing the molecular mechanisms and signalling pathways involved. Further, we highlight the challenges and future directions in the application of GLP-1 analogues for fertility treatment.